West Pharmaceutical Services, Inc. Stock Mexican S.E.
Stocks
WST *
US9553061055
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Mexican S.E.
2025-12-04
|
5-day change | 1st Jan Change | ||
| 5,112.51 MXN | +15.28% |
|
-.--% | - |
| 10-13 | TD Cowen Adjusts Price Target on West Pharmaceutical Services to $420 From $410 | MT |
| 10-07 | Evercore ISI Adjusts West Pharmaceutical Services Price Target to $440 From $410 | MT |
| Market Cap | 26.96B 497B 24.04B 22.3B 20.31B 38.24B 2,562B 38.96B 268B 105B 1,335B 101B 99B 4,261B | P/E 2026 * |
44.7x | P/E 2027 * | 38.8x |
|---|---|---|---|---|---|
| Enterprise Value | 26.45B 487B 23.59B 21.89B 19.93B 37.52B 2,514B 38.23B 263B 103B 1,310B 99.24B 97.15B 4,181B | EV / Sales 2026 * |
7.84x | EV / Sales 2027 * | 7.24x |
| Free-Float |
92.88% | Yield 2026 * |
0.24% | Yield 2027 * | 0.25% |
Last Transcript: West Pharmaceutical Services, Inc.
| 1 day | +15.28% |
| 1 year | 5,112.51 | 5,112.51 | |
| 3 years | 4,000 | 7,104.95 | |
| 5 years | 4,000 | 9,649 | |
| 10 years | 4,000 | 9,649 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michel Lagarde
CEO | Chief Executive Officer | 52 | 2026-08-30 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 2025-08-03 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 2025-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 2011-01-31 |
Douglas Michels
BRD | Director/Board Member | 69 | 2011-03-06 |
William Feehery
BRD | Director/Board Member | 56 | 2012-02-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +15.28% | -.--% | - | - | 26.37B | ||
| +2.29% | +6.03% | -21.45% | +15.20% | 178B | ||
| +1.29% | +11.62% | -1.13% | +32.64% | 121B | ||
| +4.12% | +6.47% | -20.75% | +13.71% | 108B | ||
| +0.41% | +1.40% | -45.37% | -9.38% | 75.7B | ||
| +1.56% | +7.62% | +7.39% | +80.66% | 64.15B | ||
| -1.75% | -0.72% | +17.66% | +59.66% | 53.49B | ||
| +2.58% | +7.55% | +2.87% | -25.10% | 51.45B | ||
| +3.43% | +8.00% | -14.09% | +28.39% | 41.68B | ||
| +5.08% | +4.05% | +32.47% | +15.12% | 31.5B | ||
| Average | +3.43% | +3.49% | -4.71% | +23.43% | 80.52B | |
| Weighted average by Cap. | +2.51% | +4.21% | -10.53% | +22.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.38B 62.2B 3.01B 2.79B 2.54B 4.79B 321B 4.88B 33.57B 13.14B 167B 12.66B 12.4B 533B | 3.59B 66.11B 3.2B 2.97B 2.7B 5.09B 341B 5.18B 35.68B 13.97B 178B 13.46B 13.17B 567B |
| Net income | 619M 11.4B 552M 512M 466M 878M 58.81B 894M 6.15B 2.41B 30.64B 2.32B 2.27B 97.8B | 710M 13.08B 633M 587M 535M 1.01B 67.45B 1.03B 7.06B 2.76B 35.14B 2.66B 2.61B 112B |
| Net Debt | -503M -9.27B -449M -416M -379M -714M -47.83B -727M -5.01B -1.96B -24.92B -1.89B -1.85B -79.55B | -973M -17.94B -868M -805M -734M -1.38B -92.53B -1.41B -9.68B -3.79B -48.21B -3.65B -3.58B -154B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WST Stock
- WST * Stock
Select your edition
All financial news and data tailored to specific country editions
















